1. A retrospective serological survey on human babesiosis in Belgium
L. Lempereur, B. Shiels, P. Heyman, E. Moreau, C. Saegerman, B. Losson, L. Malandrin 
Clinical Microbiology and Infection 
Volume 21, Issue 1, Pages 96.e1-96.e7 (January 2015)
DOI: /j.cmi
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

2. Fig. 1
Indirect fluorescent antibody test-reactivity of serum from a human clinical case of babesiosis in Finland [27] at dilution 1:8 using B. divergens parasites as antigen.
Clinical Microbiology and Infection  , 96.e1-96.e7DOI: ( /j.cmi )
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

3. Fig. 2
4, 6-diamindino-2-phenylindole nucleic acid stain (DAPI) staining of serum from a human clinical case of babesiosis in Finland [27] at dilution 1:8 using B. divergens parasites as antigen.
Clinical Microbiology and Infection  , 96.e1-96.e7DOI: ( /j.cmi )
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

4. Fig. 3
Reactivity of serum (dilution 1: 80) obtained from cattle in France infected with B. divergens [26] using a B. divergens IFA test.
Clinical Microbiology and Infection  , 96.e1-96.e7DOI: ( /j.cmi )
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions